Report Detail
Global Poultry Live Attenuated Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4586059 |
- 09 April, 2024 |
- Global |
- 113 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Poultry Live Attenuated Vaccine market size was valued at USD 2196.8 million in 2023 and is forecast to a readjusted size of USD 2695.7 million by 2030 with a CAGR of 3.0% during review period.
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird's immune system to develop a protective response without causing severe illness.
The Global Info Research report includes an overview of the development of the Poultry Live Attenuated Vaccine industry chain, the market status of Chicken (NDV, Marek ' s Disease), Other Poultry (NDV, Marek ' s Disease), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poultry Live Attenuated Vaccine.
Regionally, the report analyzes the Poultry Live Attenuated Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poultry Live Attenuated Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poultry Live Attenuated Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poultry Live Attenuated Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., NDV, Marek ' s Disease).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poultry Live Attenuated Vaccine market.
Regional Analysis: The report involves examining the Poultry Live Attenuated Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poultry Live Attenuated Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poultry Live Attenuated Vaccine:
Company Analysis: Report covers individual Poultry Live Attenuated Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poultry Live Attenuated Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chicken, Other Poultry).
Technology Analysis: Report covers specific technologies relevant to Poultry Live Attenuated Vaccine. It assesses the current state, advancements, and potential future developments in Poultry Live Attenuated Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poultry Live Attenuated Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poultry Live Attenuated Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Other
Market segment by Application
Chicken
Other Poultry
Major players covered
MERCK
Boehringer Ingelheim
CEVA
ZOETIS
Vaxxinova
ELANCO
QYH BIOTECH
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
HARBIN PHARMACEUTICAL GROUP
MEVAC
VENKY’S
Dechra
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Poultry Live Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poultry Live Attenuated Vaccine, with price, sales, revenue and global market share of Poultry Live Attenuated Vaccine from 2019 to 2024.
Chapter 3, the Poultry Live Attenuated Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poultry Live Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poultry Live Attenuated Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poultry Live Attenuated Vaccine.
Chapter 14 and 15, to describe Poultry Live Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Poultry Live Attenuated Vaccine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 NDV
- 1.3.3 Marek ' s Disease
- 1.3.4 IBD
- 1.3.5 Infectious Bronchitis
- 1.3.6 Influenza
- 1.3.7 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Chicken
- 1.4.3 Other Poultry
- 1.5 Global Poultry Live Attenuated Vaccine Market Size & Forecast
- 1.5.1 Global Poultry Live Attenuated Vaccine Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Poultry Live Attenuated Vaccine Sales Quantity (2019-2030)
- 1.5.3 Global Poultry Live Attenuated Vaccine Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 MERCK
- 2.1.1 MERCK Details
- 2.1.2 MERCK Major Business
- 2.1.3 MERCK Poultry Live Attenuated Vaccine Product and Services
- 2.1.4 MERCK Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 MERCK Recent Developments/Updates
- 2.2 Boehringer Ingelheim
- 2.2.1 Boehringer Ingelheim Details
- 2.2.2 Boehringer Ingelheim Major Business
- 2.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product and Services
- 2.2.4 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Boehringer Ingelheim Recent Developments/Updates
- 2.3 CEVA
- 2.3.1 CEVA Details
- 2.3.2 CEVA Major Business
- 2.3.3 CEVA Poultry Live Attenuated Vaccine Product and Services
- 2.3.4 CEVA Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 CEVA Recent Developments/Updates
- 2.4 ZOETIS
- 2.4.1 ZOETIS Details
- 2.4.2 ZOETIS Major Business
- 2.4.3 ZOETIS Poultry Live Attenuated Vaccine Product and Services
- 2.4.4 ZOETIS Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 ZOETIS Recent Developments/Updates
- 2.5 Vaxxinova
- 2.5.1 Vaxxinova Details
- 2.5.2 Vaxxinova Major Business
- 2.5.3 Vaxxinova Poultry Live Attenuated Vaccine Product and Services
- 2.5.4 Vaxxinova Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Vaxxinova Recent Developments/Updates
- 2.6 ELANCO
- 2.6.1 ELANCO Details
- 2.6.2 ELANCO Major Business
- 2.6.3 ELANCO Poultry Live Attenuated Vaccine Product and Services
- 2.6.4 ELANCO Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 ELANCO Recent Developments/Updates
- 2.7 QYH BIOTECH
- 2.7.1 QYH BIOTECH Details
- 2.7.2 QYH BIOTECH Major Business
- 2.7.3 QYH BIOTECH Poultry Live Attenuated Vaccine Product and Services
- 2.7.4 QYH BIOTECH Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 QYH BIOTECH Recent Developments/Updates
- 2.8 PULIKE
- 2.8.1 PULIKE Details
- 2.8.2 PULIKE Major Business
- 2.8.3 PULIKE Poultry Live Attenuated Vaccine Product and Services
- 2.8.4 PULIKE Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 PULIKE Recent Developments/Updates
- 2.9 PHIBRO ANIMAL HEALTH CORPORATION
- 2.9.1 PHIBRO ANIMAL HEALTH CORPORATION Details
- 2.9.2 PHIBRO ANIMAL HEALTH CORPORATION Major Business
- 2.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product and Services
- 2.9.4 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
- 2.10 HARBIN PHARMACEUTICAL GROUP
- 2.10.1 HARBIN PHARMACEUTICAL GROUP Details
- 2.10.2 HARBIN PHARMACEUTICAL GROUP Major Business
- 2.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product and Services
- 2.10.4 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
- 2.11 MEVAC
- 2.11.1 MEVAC Details
- 2.11.2 MEVAC Major Business
- 2.11.3 MEVAC Poultry Live Attenuated Vaccine Product and Services
- 2.11.4 MEVAC Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 MEVAC Recent Developments/Updates
- 2.12 VENKY’S
- 2.12.1 VENKY’S Details
- 2.12.2 VENKY’S Major Business
- 2.12.3 VENKY’S Poultry Live Attenuated Vaccine Product and Services
- 2.12.4 VENKY’S Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 VENKY’S Recent Developments/Updates
- 2.13 Dechra
- 2.13.1 Dechra Details
- 2.13.2 Dechra Major Business
- 2.13.3 Dechra Poultry Live Attenuated Vaccine Product and Services
- 2.13.4 Dechra Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.13.5 Dechra Recent Developments/Updates
3 Competitive Environment: Poultry Live Attenuated Vaccine by Manufacturer
- 3.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Poultry Live Attenuated Vaccine Revenue by Manufacturer (2019-2024)
- 3.3 Global Poultry Live Attenuated Vaccine Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Poultry Live Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2023
- 3.4.2 Top 6 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2023
- 3.5 Poultry Live Attenuated Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Poultry Live Attenuated Vaccine Market: Region Footprint
- 3.5.2 Poultry Live Attenuated Vaccine Market: Company Product Type Footprint
- 3.5.3 Poultry Live Attenuated Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Poultry Live Attenuated Vaccine Market Size by Region
- 4.1.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2030)
- 4.1.2 Global Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2030)
- 4.1.3 Global Poultry Live Attenuated Vaccine Average Price by Region (2019-2030)
- 4.2 North America Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
- 4.3 Europe Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
- 4.4 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
- 4.5 South America Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
- 4.6 Middle East and Africa Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
- 5.2 Global Poultry Live Attenuated Vaccine Consumption Value by Type (2019-2030)
- 5.3 Global Poultry Live Attenuated Vaccine Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
- 6.2 Global Poultry Live Attenuated Vaccine Consumption Value by Application (2019-2030)
- 6.3 Global Poultry Live Attenuated Vaccine Average Price by Application (2019-2030)
7 North America
- 7.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
- 7.2 North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
- 7.3 North America Poultry Live Attenuated Vaccine Market Size by Country
- 7.3.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
- 7.3.2 North America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
- 8.2 Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
- 8.3 Europe Poultry Live Attenuated Vaccine Market Size by Country
- 8.3.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Poultry Live Attenuated Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
- 10.2 South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
- 10.3 South America Poultry Live Attenuated Vaccine Market Size by Country
- 10.3.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
- 10.3.2 South America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Poultry Live Attenuated Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Poultry Live Attenuated Vaccine Market Drivers
- 12.2 Poultry Live Attenuated Vaccine Market Restraints
- 12.3 Poultry Live Attenuated Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Poultry Live Attenuated Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Poultry Live Attenuated Vaccine
- 13.3 Poultry Live Attenuated Vaccine Production Process
- 13.4 Poultry Live Attenuated Vaccine Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Poultry Live Attenuated Vaccine Typical Distributors
- 14.3 Poultry Live Attenuated Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Poultry Live Attenuated Vaccine. Industry analysis & Market Report on Poultry Live Attenuated Vaccine is a syndicated market report, published as Global Poultry Live Attenuated Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Poultry Live Attenuated Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
